This session provides an overview of the Startup Exchange program, and how startups can engage. It is intended for MIT-connected startups that are new to the program as well as others that might have registered a while ago and pivoted or achieved significant milestones.
Join MIT Startup Exchange to hear from MIT-connected startups who are focusing efforts on aspects of COVID-19.
A leading pharmaceutical company in Amyotrophic Lateral Sclerosis (ALS) is interested in speaking with startups whose technology could contribute to very early diagnosis of the disease.